• About Us
    • Contact Us
    • Login
    • ObGFirst
  • COVID-19
  • Alerts
  • OB
  • 2T US Atlas
  • The Genome
  • GYN
    • GYN
    • Sexual Health
  • Primary Care
  • Your Practice
  • GrandRounds
  • My Bookshelf
  • Now@ObG
  • Media
About Us Contact Us Login ObGFirst
  • COVID-19
  • Alerts
  • OB
  • 2T US Atlas
  • The Genome
  • GYN
    • GYN
    • Sexual Health
  • Primary Care
  • Your Practice
  • GrandRounds
  • My Bookshelf
  • Now@ObG
  • Media
Grand Rounds

Results from the VITAMINS Trial: Does Combining Hydrocortisone Treatment with Vitamin C and Thiamine Improve Sepsis Outcomes?

image_pdfFavoriteLoadingFavorite

BACKGROUND AND PURPOSE:

  • Vitamin C has been studied, due to its anti-inflammatory and antioxidant properties, as a possible addition to sepsis protocols
    • Thiamine has been included in some protocols due to frequency of thiamine deficiency in patients with sepsis
  • Fujii et al. (JAMA, 2020) assessed whether the combination of vitamin C, hydrocortisone, and thiamine, compared with hydrocortisone alone, improves the duration of time alive and free of vasopressor administration in patients with septic shock

METHODS:

  • Multicenter, open-label, randomized clinical trial (RCT)
    • Vitamin C, Hydrocortisone and Thiamine in Patients With Septic Shock (VITAMINS)
  • Participants
    • Patients in septic shock
  • Randomization arms
    • Intervention group
      • Intravenous vitamin C (1.5 g every 6 hours) | Hydrocortisone (50 mg every 6 hours) | Thiamine (200 mg every 12 hours)
    • Control group
      • Intravenous hydrocortisone (50 mg every 6 hours) alone
  • Study design
    • Treatment continued until shock resolution or up to 10 days
  • Primary outcome
    • Duration of time alive and free of vasopressor administration up to day 7
  • Secondary outcomes
    • 28-day, 90-day, ICU, and hospital mortality | 28-day cumulative vasopressor-free days, mechanical ventilation-free days, renal replacement therapy–free days | Change in SOFA score at day 3 | 28-day ICU free-days | Hospital length of stay

RESULTS:

  • 216 patients were randomized | 109 to intervention group | 107 to control group
    • Mean age: 61.7 years
  • Primary outcome: Time alive and vasopressor free up to day 7
    • Intervention group: 122.1 hours
    • Control group: 124.6 hours
  • The median difference was not statistically significant (–0.6 hours ; P = 0.83)
  • Of the prespecified secondary outcomes the only difference seen was in the change in median SOFA score at day 3
    • Intervention group: –2
    • Control group: –1
    • Difference: –1.0 (95% CI, –1.9 to –0.1; P = .02)
  • Serious adverse events or suspected unexpected serious events: None reported

CONCLUSION:

  • Treatment with a vitamin C, hydrocortisone, and thiamine in combination did not improve sepsis outcomes
  • Improvement in SOFA score should be interpreted with caution | Potential for bias for competing risks in opposite directions (patients who were healthier would have been discharged from the ICU and not accounted for)

Learn More – Primary Sources:

Effect of Vitamin C, Hydrocortisone, and Thiamine vs Hydrocortisone Alone on Time Alive and Free of Vasopressor Support Among Patients With Septic Shock – The VITAMINS Randomized Clinical Trial

Now You Can Get ObG Clinical Research Summaries Direct to Your Phone, with ObGFirst

Try it Free »

image_pdfFavoriteLoadingFavorite
< Previous
All Grand Rounds Posts
Next >

Related ObG Topics:

SMFM & CMQCC Guidelines: Making the Diagnosis of Sepsis in Pregnancy
SMFM & CMQCC Guidelines: Management of Sepsis in Pregnancy
Sepsis and Sepsis-Related Maternal Mortality in the U.S. – Does it Happen More Than We Think?
Do Mandated Sepsis Procedures Reduce Sepsis-Related Deaths?
WOMAN Trial Secondary Analysis: Do Invasive Treatments for PPH Increase Sepsis Risk?

Sections

  • COVID-19
  • Alerts
  • OB
  • GYN
    • GYN
    • Sexual Health
  • 2T US Atlas
  • The Genome
  • Primary Care
  • Your Practice
  • Grand Rounds
  • My Bookshelf
  • Now@ObG
  • Media

Are you an
ObG Insider?

Get specially curated clinical summaries delivered to your inbox every week for free

  • Site Map/
  • © ObG Project/
  • Terms and Conditions/
  • Privacy/
  • Contact Us/
© ObG Project
SSL Certificate


  • Already an ObGFirst Member?
    Welcome back

    Log In

    Want to sign up?
    Get guideline notifications
    CME Included

    Sign Up

Get Guideline Alerts Direct to Your Phone
Try ObGFirst Free!

Sign In

Lost your password?

Sign Up for ObGFirst and Stay Ahead

  • - Professional guideline notifications
  • - Daily summary of a clinically relevant
    research paper
  • - Includes 1 hour of CME every month

ObGFirst Free Trial

Already a Member of ObGFirst®?

Please log in to ObGFirst to access the 2T US Atlas

Password Trouble?

Not an ObGFirst® Member Yet?

  • - Access 2T US Atlas
  • - Guideline notifications
  • - Daily research paper summaries
  • - And lots more!
ObGFirst Free Trial

Media - Internet

Computer System Requirements

OBG Project CME requires a modern web browser (Internet Explorer 10+, Mozilla Firefox, Apple Safari, Google Chrome, Microsoft Edge). Certain educational activities may require additional software to view multimedia, presentation, or printable versions of their content. These activities will be marked as such and will provide links to the required software. That software may be: Adobe Flash, Apple QuickTime, Adobe Acrobat, Microsoft PowerPoint, Windows Media Player, or Real Networks Real One Player.

Disclosure of Unlabeled Use

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications.

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Disclaimer

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information
presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.

Jointly provided by

NOT ENOUGH CME HOURS

It appears you don't have enough CME Hours to take this Post-Test. Feel free to buy additional CME hours or upgrade your current CME subscription plan

Subscribe

JOIN OBGFIRST AND GET CME/CE CREDITS

One of the benefits of an ObGFirst subscription is the ability to earn CME/CE credits from the ObG entries you read. Tap the button to learn more about ObGFirst

Learn More
Leaving ObG Website

You are now leaving the ObG website and on your way to PRIORITY at UCSF, an independent website. Therefore, we are not responsible for the content or availability of this site